202 related articles for article (PubMed ID: 27317646)
21. Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds.
Dhumal ST; Deshmukh AR; Bhosle MR; Khedkar VM; Nawale LU; Sarkar D; Mane RA
Bioorg Med Chem Lett; 2016 Aug; 26(15):3646-51. PubMed ID: 27301367
[TBL] [Abstract][Full Text] [Related]
22. Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.
Boechat N; Ferreira VF; Ferreira SB; de Lourdes G Ferreira M; de C da Silva F; Bastos MM; Dos S Costa M; Lourenço MC; Pinto AC; Krettli AU; Aguiar AC; Teixeira BM; da Silva NV; Martins PR; Bezerra FA; Camilo AL; da Silva GP; Costa CC
J Med Chem; 2011 Sep; 54(17):5988-99. PubMed ID: 21776985
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of N-(aryl)-2-thiophen-2-ylacetamides series as a new class of antitubercular agents.
Silva Lourenço MC; Rodrigues Vicente F; de Oliveira Henriques Md; Peixoto Candéa AL; Borges Gonçalves RS; Nogueira TC; de Lima Ferreira M; Nora de Souza MV
Bioorg Med Chem Lett; 2007 Dec; 17(24):6895-8. PubMed ID: 17967538
[TBL] [Abstract][Full Text] [Related]
25. Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives.
Banu S; Bollu R; Nagarapu L; Nanubolu JB; Yogeswari P; Sriram D; Gunda SK; Vardhan D
Chem Biol Drug Des; 2018 Jul; 92(1):1315-1323. PubMed ID: 29624868
[TBL] [Abstract][Full Text] [Related]
26. A click chemistry approach for the synthesis of mono and bis aryloxy linked coumarinyl triazoles as anti-tubercular agents.
Anand A; Naik RJ; Revankar HM; Kulkarni MV; Dixit SR; Joshi SD
Eur J Med Chem; 2015 Nov; 105():194-207. PubMed ID: 26491982
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
Phatak PS; Bakale RD; Kulkarni RS; Dhumal ST; Dixit PP; Krishna VS; Sriram D; Khedkar VM; Haval KP
Bioorg Med Chem Lett; 2020 Nov; 30(22):127579. PubMed ID: 32987135
[TBL] [Abstract][Full Text] [Related]
28. One pot solvent free synthesis and in vitro antitubercular screening of 3-Aracylphthalides against Mycobacterium tuberculosis.
Limaye RA; Kumbhar VB; Natu AD; Paradkar MV; Honmore VS; Chauhan RR; Gample SP; Sarkar D
Bioorg Med Chem Lett; 2013 Feb; 23(3):711-4. PubMed ID: 23265877
[TBL] [Abstract][Full Text] [Related]
29. An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition.
Reddy KI; Srihari K; Renuka J; Sree KS; Chuppala A; Jeankumar VU; Sridevi JP; Babu KS; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Dec; 22(23):6552-6563. PubMed ID: 25456076
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents.
Kim S; Cho SN; Oh T; Kim P
Bioorg Med Chem Lett; 2012 Nov; 22(22):6844-7. PubMed ID: 23058885
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, biological activity, and evaluation of the mode of action of novel antitubercular benzofurobenzopyrans substituted on A ring.
Termentzi A; Khouri I; Gaslonde T; Prado S; Saint-Joanis B; Bardou F; Amanatiadou EP; Vizirianakis IS; Kordulakova J; Jackson M; Brosch R; Janin YL; Daffé M; Tillequin F; Michel S
Eur J Med Chem; 2010 Dec; 45(12):5833-47. PubMed ID: 20961671
[TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors.
Suresh A; Srinivasarao S; Agnieszka N; Ewa AK; Alvala M; Lherbet C; Chandra Sekhar KVG
Chem Biol Drug Des; 2018 Jun; 91(6):1078-1086. PubMed ID: 29063733
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, in vitro and in silico studies of 2, 3-diaryl benzofuran derivatives as antitubercular agents.
Bhukya B; Shukla A; Chaturvedi V; Trivedi P; Kumar S; Khan F; Negi AS; Srivastava SK
Bioorg Chem; 2020 Jun; 99():103784. PubMed ID: 32361184
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives.
Sajja Y; Vanguru S; Vulupala HR; Nagarapu L; Perumal Y; Sriram D; Nanubolu JB
Chem Biol Drug Des; 2017 Oct; 90(4):496-500. PubMed ID: 28267891
[TBL] [Abstract][Full Text] [Related]
35. 5-Chloro-2-thiophenyl-1,2,3-triazolylmethyldihydroquinolines as dual inhibitors of Mycobacterium tuberculosis and influenza virus: Synthesis and evaluation.
Marvadi SK; Krishna VS; Sinegubova EO; Volobueva AS; Esaulkova YL; Muryleva AA; Tentler DG; Sriram D; Zarubaev VV; Kantevari S
Bioorg Med Chem Lett; 2019 Sep; 29(18):2664-2669. PubMed ID: 31375291
[TBL] [Abstract][Full Text] [Related]
36. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, in silico, and in vitro evaluation of 3-phenylpyrazole acetamide derivatives as antimycobacterial agents.
Gaikwad NB; Nirmale K; Sahoo SK; Ahmad MN; Kaul G; Shukla M; Nanduri S; Das Gupta A; Chopra S; Yaddanapudi MV
Arch Pharm (Weinheim); 2021 May; 354(5):e2000349. PubMed ID: 33351199
[TBL] [Abstract][Full Text] [Related]
38. Clubbed triazoles: a novel approach to antitubercular drugs.
Shiradkar M; Suresh Kumar GV; Dasari V; Tatikonda S; Akula KC; Shah R
Eur J Med Chem; 2007 Jun; 42(6):807-16. PubMed ID: 17239490
[TBL] [Abstract][Full Text] [Related]
39. Antimycobacterial activity of diphenylpyraline derivatives.
Weis R; Faist J; di Vora U; Schweiger K; Brandner B; Kungl AJ; Seebacher W
Eur J Med Chem; 2008 Apr; 43(4):872-9. PubMed ID: 17714832
[TBL] [Abstract][Full Text] [Related]
40. Antitubercular activity of 1,2,3-triazolyl fatty acid derivatives.
Ghiano DG; de la Iglesia A; Liu N; Tonge PJ; Morbidoni HR; Labadie GR
Eur J Med Chem; 2017 Jan; 125():842-852. PubMed ID: 27750201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
